This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1977-1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1977-1988
Title: The Innovative Contributions of Robert Ye-Fong Ning
Introduction
Robert Ye-Fong Ning is a notable inventor based in West Caldwell, NJ (US). He has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a total of 2 patents, his work focuses on the development of compounds that have potential applications in medicine.
Latest Patents
Ning's latest patents include groundbreaking research on the phosphorylation of cyclic amides. This process involves reacting compounds of a specific formula with a strong base and a phosphorylating agent to produce valuable intermediates. These intermediates can be utilized in the production of pharmaceutically valuable compounds. Another significant patent involves the synthesis of indoloquinolines, which are described as derivatives that can serve as anti-tumor agents by inhibiting the growth of transplantable tumors.
Career Highlights
Robert Ye-Fong Ning is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at the company has allowed him to contribute to the development of innovative solutions that address critical health challenges.
Collaborations
Throughout his career, Ning has collaborated with esteemed colleagues such as Rodney I Fryer and Leo Henryk Sternbach. These collaborations have further enhanced the impact of his inventions in the pharmaceutical field.
Conclusion
Robert Ye-Fong Ning's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
